About Us

About Us

Mission

Manufacturers have to be more than just providers of a product. We have to innovate, invent, and contribute to society and the betterment of the health and welfare of the planet. Human Biosciences has been doing just that for nearly 30 years.

Our flagship Kollagen(tm) advanced wound care products have become the world standard for wound care of all types. Kollagen products have brought happiness and positive solutions to patients in nearly every land who suffer from the pain and limitations brought by basic, chronic, and hard-to-heal wounds.

Until the early 1990s, the wound healing industry was made up of a small number of products. Wet to dry dressings were the standard using simple cotton gauze. That all changed when our founder, Dr. Manoj K Jain, discovered how to preserve the collagen molecule and manufacture products. This molecule, when properly preserved, would create the foundation for our business and the entire advanced wound care industry.

In 1991, the FDA approved for sale Kollagen products based on Dr. Jain’s collagen technology. With these products, healthcare professionals gained the ability to directly interact with the wound and take control of the healing process for the first time. After 10 years of extensive use, the Department of Health and Human Services listened to clinicians, recognized these benefits, and created an entirely new category of Medicare reimbursement codes for collagen. The new availability of insurance payments for collagen products would pave the way for other collagen products to be developed. Ultimately, it would take ten years after the release of our first Kollagen products for a competitor to receive FDA approval for a collagen product. Now collagen is the standard for wound care, and Kollagen is the standard for collagen.

We believe that every patient matters and every wound matters.

That sentiment leads our decision-making, our ethic, our ethos. We’re known as thought-leaders in the world of advanced wound care for a reason—we bear down on innovation and distribution of helpful products. That is how we pioneered the advanced wound care industry over thirty years ago with the development of Kollagen.

Since then, we continually find ways to streamline our manufacturing operations to keep prices fair and our product in the hands of the people who need it most. We are always growing and retooling our portfolio of products to meet the exacting standards and changing requirements of physicians, scientists, hospitals, patients and caregivers.

Our collagen-based products are breaking barriers in wound healing across the globe. We feature 100% non-hydrolyzed native bovine collagen products in their purest form.

Human BioSciences’ proprietary Kollagen™ technology process protects and retains significantly more native triple helical protein structure thus allowing superior stability of the molecule and scaffolding through all four phases of wound healing.

For use and management of burns, scrapes, blisters (ruptured), sores, ulcers, acute and chronic wounds, superficial, partial and full thickness wounds, infected and non-infected wounds, and minimal to heavily exudating wounds. Easy application and product compatibility with topical agents and or dressings.

Not all patients are the same.

Not all wounds are the same.

Quality matters.

Our Kollagen™ technology launched the international advanced woundcare industry in 1991, and we continue to engineer breakthroughs every day.

Our guiding philosophy is that every patient matters and every wound matters. In that spirit, we have dozens of new products in development at any given time to solve each of our patient’s individual problems. Our vision encompasses pharmaceuticals, nutraceuticals, additive manufacturing, alternative medicine based in real science and eco-friendly techniques to manufacture amazing products with scientific integrity.

In order to reach as many patients as possible, our products are distributed around the world via a robust global distribution network. Our manufacturing facilities in the USA, India, and Taiwan are equipped with our state-of-the-art proprietary machinery. Each of our facilities exceed all quality standards and achieve unmatched yields which can support new product launches and expansion beyond their respective markets. We are planning to supplement this expansion into new markets by establishing new facilities around the world in a series of joint venture partnerships.

Rohan K Jain

Dr. Rohan K Jain is responsible for the company’s overall operations with a focus on research and development. Dr. Jain has more than 10 years of experience in the medical device industry. He has supervised and conducted extensive research in the collagen, biomaterials, and protein space resulting in the release of numerous products to the market. Additionally, he oversees an expansive pipeline of new products for the company. Dr. Jain was also a capital markets attorney at Shearman & Sterling LLP. He received his Doctorate in Law and his MBA from New York University. He received his Bachelor’s degrees in Biomedical Engineering and Materials Science and his Master’s in Engineering Management from Johns Hopkins University. He is a member of the New York and Maryland bars.

Gerhard Gobel

Dr. Gobel is responsible for the company’s physical infrastructure and global expansion efforts through partnerships. Prior to joining HBS, Dr. Gobel was Managing Director at the Graf Matuschka Group in Munich, Germany, where he was actively involved in restructuring and privatization in East Germany and Eastern Europe. He was also a member of the American group of the EBRD European Bank for Reconstruction and Development in the privatization of the Russian economy and military complex. He has over forty years’ experience in many different industries including medical devices, pharmacy, and others. Dr. Gobel earned his Doctorate and Postdoctoral degrees in Economics in East Berlin.

Henry Hall

Dr. Hall is responsible for finance, M&A and joint ventures, both domestically and internationally. Prior to joining HBS, Dr. Hall was an entrepreneur and investment banker having spent over 20 years at Merrill Lynch, Credit Suisse and JP Morgan. He received his JD from Harvard Law School, worked at law firm Skadden and is a member of the New York Bar. Dr. Hall is a Chartered Financial Analyst (CFA) and Certified Management Account (CMA).

Cheryl Carver

Ms. Carver is responsible for clinical education and training initiatives servicing patients, medical professionals, and institutions. Ms. Carver has amassed a wealth of clinical knowledge and industry experience in her more than 20 years as an LPN board certified wound care nurse. She has authored over 180 published white papers, ebooks, blogs, and articles. Ms. Carver is WCC certified by the National Alliance of Wound Care and Ostomy and CWCA certified by the American Board of Wound Management. She is on the Board of Directors of the American College of Professional Wound Associates, among other leadership roles. Check out her blog at https://www.woundsource.com/users/cheryl-carver

Jigar Patel

Mr. Patel is responsible for the company’s manufacturing, supply chain, and product fulfillment. Mr. Patel has ten years of experience producing and developing collagen products and implementing their manufacturing processes. With an MBA in Pharmaceutical Healthcare and a bachelor’s in Pharmaceuticals, Mr. Patel brings deep technical knowledge and rich people management experience.

Jack Slovick

Mr. Slovick is responsible for all regulatory and quality affairs in the company. Mr. Slovick has worked in regulatory, quality, and clinical services within the medical device and diagnostics industry for nearly 40 years. He founded Methodize Inc., to offer strategic support for approval of medical devices and in vitro diagnostics products. Mr. Slovick has a Bachelor’s degree in Management Information Systems.

Nisha Jain

Ms. Jain is responsible for branding, design and public outreach efforts for the company. Ms. Jain has over five year’s experience in the creative design arena. She has spearheaded multiple marketing campaigns, both domestic and international. She also has experience producing several television and live stage programs. She has a Bachelor’s Degree in Film and Video Studies from George Mason University.

Laksh Agarwal

Mr. Agarwal is responsible for Corporate Business Development, Sales, and Product Development, both locally and internationally for the company. Mr. Agarwal has over six years of corporate sales and business development experience. He completed his Master of Science in Engineering Management degree from Johns Hopkins University with a technical concentration in Mechanical Engineering. In the past, he has also worked as a fundraising volunteer for three years and thus gained insights in community fundraising and business development. Additionally, he has interned at a manufacturing firm and understood various intricacies involved in manufacturing ranging from the floor level to the supply chain. He has published a paper on Omni Channel Supply Chain and is a certified Lean Six Sigma associate. He has also interned as a business development consultant to a startup for market research and pricing strategies in Israel. Equipped with a combination of management and technical background acquired from his diverse experiences and education, he is perfectly suited to lead the business development efforts for Human BioSciences.

People

Gerhard Gobel

Dr. Gobel is responsible for the company’s physical infrastructure and global expansion efforts through partnerships.
Prior to joining HBS, Dr. Gobel was Managing Director at the Graf Matuschka Group in Munich, Germany, where he was actively involved in restructuring and privatization in East Germany and Eastern Europe. He was also a member of the American group of the EBRD European Bank for Reconstruction and Development in the privatization of the Russian economy and military complex. He has over forty years’ experience in many different industries including medical devices, pharmacy, and others.
Dr. Gobel earned his Doctorate and Postdoctoral degrees in Economics in East Berlin.

Henry Hall

Dr. Hall is responsible for finance, M&A and joint ventures, both domestically and internationally.
Prior to joining HBS, Dr. Hall was an entrepreneur and investment banker having spent over 20 years at Merrill Lynch, Credit Suisse and JP Morgan. He received his JD from Harvard Law School, worked at law firm Skadden and is a member of the New York Bar. Dr. Hall is a Chartered Financial Analyst (CFA) and Certified Management Account (CMA).

Cheryl Carver

Ms. Carver is responsible for clinical education and training initiatives servicing patients, medical professionals, and institutions.
Ms. Carver has amassed a wealth of clinical knowledge and industry experience in her more than 20 years as an LPN board certified wound care nurse. She has authored over 180 published white papers, ebooks, blogs, and articles. Ms. Carver is WCC certified by the National Alliance of Wound Care and Ostomy and CWCA certified by the American Board of Wound Management. She is on the Board of Directors of the American College of Professional Wound Associates, among other leadership roles.

Jigar Patel

Mr. Patel is responsible for the company’s manufacturing, supply chain, and product fulfillment.
Mr. Patel has ten years of experience producing and developing collagen products and implementing their manufacturing processes. With an MBA in Pharmaceutical Healthcare and a bachelor’s in Pharmaceuticals, Mr. Patel brings deep technical knowledge and rich people management experience.

Jack Slovick

Mr. Slovick is responsible for all regulatory and quality affairs in the company.
Mr. Slovick has worked in regulatory, quality, and clinical services within the medical device and diagnostics industry for nearly 40 years. He founded Methodize Inc., to offer strategic support for approval of medical devices and in vitro diagnostics products. Mr. Slovick has a Bachelor’s degree in Management Information Systems.

Nisha Jain

Ms. Jain is responsible for branding, design and public outreach efforts for the company.
Ms. Jain has over five year’s experience in the creative design arena. She has spearheaded multiple marketing campaigns, both domestic and international. She also has experience producing several television and live stage programs. She has a Bachelor’s Degree in Film and Video Studies from George Mason University.

Laksh Agarwal

Mr. Agarwal is responsible for Corporate Business Development, Sales, and Product Development, both locally and internationally for the company.
Mr. Agarwal has over six years of corporate sales and business development experience. He completed his Master of Science in Engineering Management degree from Johns Hopkins University with a technical concentration in Mechanical Engineering. In the past, he has also worked as a fundraising volunteer for three years and thus gained insights in community fundraising and business development. Additionally, he has interned at a manufacturing firm and understood various intricacies involved in manufacturing ranging from the floor level to the supply chain. He has published a paper on Omni Channel Supply Chain and is a certified Lean Six Sigma associate. He has also interned as a business development consultant to a startup for market research and pricing strategies in Israel. Equipped with a combination of management and technical background acquired from his diverse experiences and education, he is perfectly suited to lead the business development efforts for Human BioSciences.

1989

HBS is founded by Dr. Manoj K Jain in Kansas

1990

HBS receives several research grants

1991

Kollagen™ is developed- the world’s first collagen wound care dressings are approved by the FDA

1994

First collagen veterinary products are developed

1998

Patent for collagen processing is issued

1999

New headquarters established in Maryland

2000

Special medicare reimbursement codes are developed for collagen products, paving the way for the industry

2002

First Taiwan joint venture is opened

2003

A new line of collagen products are approved by the FDA

2004

Company is rebranded to Human BioSciences

2006

Dr. Jain receives the Thomas Alva Edison patent award

2008

Kollagen products are approved as lifesaving drugs in India

2010

HBS opens a lab in Germany

2012

Indian facility starts production

2017

multiple new products and systems under development in USA, India and Germany.

2018

Breakthrough new manufacturing technology is developed in USA.

2018

Acquired IP for a line of non-prescription health products from schoening inGermany.

2019

30 year anniversary of HBS

2020

Flagship manufacturing facility is fully outfitted with new manufacturing technology